Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of
1934
March
29, 2019
Date of Report
(Date of earliest event reported)
|
|
|
SANUWAVE HEALTH, INC.
|
|
(Exact
name of registrant as specified in its charter)
|
|
Nevada
|
000-52985
|
20-1176000
|
|
(State or other
jurisdiction of
incorporation)
|
(Commission File
Number)
|
(IRS
Employer Identification
No.)
|
|
3360
Martin Farm Road, Suite 100, Suwanee, Georgia
|
30024
|
|
(Address of
principal executive offices)
|
(Zip
Code)
|
(770)
419-7525
Registrant’s
telephone number, including area code
N/A
(Former
name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registration is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or
Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company. ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02
Results of Operations and Financial Condition.
On
March 29, 2019, SANUWAVE Health, Inc., a Nevada Corporation (the
"Company"), announced its financial results for the year ended
December 31, 2018 and provided a business update via conference
call. A copy of the related press release is furnished as
Exhibit 99.1 to
this Form 8-K. A copy of the transcript of such call is furnished
as Exhibit 99.2 to
this Form 8-K.
The
information in this Item 2.02 of this Current Report on Form 8-K
and the exhibits attached hereto shall not be deemed to be "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, and shall not be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such
filing.
Item
9.01
Financial
Statements and Exhibits.
(d)
Exhibits.
Exhibit
No.
Description
Press release,
dated March 29, 2019, issued by SANUWAVE Health, Inc., titled
“SANUWAVE Health reports record 2018 financial results; Full
year revenue increased over 150%.”
Transcript of the
March 29, 2019, SANUWAVE Health, Inc. conference call to discuss
2018 financial results and provide a business update.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
SANUWAVE
HEALTH, INC. |
|
|
|
|
|
|
|
Date: April 3,
2019
|
By:
|
/s/ Lisa E.
Sundstrom
|
|
|
|
|
Name: Lisa E.
Sundstrom
|
|
|
|
|
Title:
Controller and
Chief Financial Officer
|
|